Akero Therapeutics Inc buy Cantor Fitzgerald
Start price
20.06.24
/
50%
€20.34
Target price
20.06.25
-
Performance (%)
16.77%
Price
05.09.24
€23.75
Summary
This prediction is currently active. The prediction currently has a performance of 16.77%. This prediction currently runs until 20.06.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Akero Therapeutics Inc | 0.806% | 0.806% |
iShares Core DAX® | -3.429% | 5.085% |
iShares Nasdaq 100 | -6.121% | 0.593% |
iShares Nikkei 225® | -7.364% | 5.479% |
iShares S&P 500 | -4.366% | 2.019% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for AKRO provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€13.80
11.10.23
11.10.23
€36.75
11.10.24
11.10.24
72.10%
05.09.24
05.09.24
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€43.60
04.10.23
04.10.23
€65.81
04.10.24
04.10.24
-46.26%
05.09.24
05.09.24
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€48.20
19.09.23
19.09.23
€64.47
19.09.24
19.09.24
-51.39%
05.09.24
05.09.24